Citations (135)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Anastasia L. Gant Kanegusuku, Clarence W. Chan, Peter H. O’Donnell & Kiang-Teck J. Yeo. (2024) Implementation of pharmacogenomics testing for precision medicine. Critical Reviews in Clinical Laboratory Sciences 61:2, pages 89-106.
Read now
Read now
Claire-Cécile Barrot, Jean-Baptiste Woillard & Nicolas Picard. (2019) Big Data in Pharmacogenomics: Current Applications, Perspectives and Pitfalls. Pharmacogenomics 20:8, pages 609-620.
Read now
Read now
Eugene Lin & Hsien-Yuan Lane. (2015) Genome-Wide Association Studies in Pharmacogenomics of Antidepressants. Pharmacogenomics 16:5, pages 555-566.
Read now
Read now
Marisol López-López, Eva Peñas-Lledó, Pedro Dorado, Alberto Ortega, Teresa Corona, Adriana Ochoa, Petra Yescas, Elisa Alonso & Adrián LLerena. (2014)
CYP2D6Genetic Polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas. Pharmacogenomics 15:15, pages 1859-1865.
Read now
Read now
Baoying Liu, H. Nida Sen & Robert Nussenblatt. (2012) Susceptibility Genes and Pharmacogenetics in Ocular Inflammatory Disorders. Ocular Immunology and Inflammation 20:5, pages 315-323.
Read now
Read now
Sarah L Hulin-Curtis, Dominique Petit, W Douglas Figg, Ann W Hsing & Juergen KV Reichardt. (2010) Finasteride Metabolism and Pharmacogenetics: New Approaches to Personalized Prevention of Prostate Cancer. Future Oncology 6:12, pages 1897-1913.
Read now
Read now
Ulrich Rabl, Christian Scharinger, Markus Müller & Lukas Pezawas. (2010) Imaging genetics: implications for research on variable antidepressant drug response. Expert Review of Clinical Pharmacology 3:4, pages 471-489.
Read now
Read now
Nilüfer Rahmioğlu & Kourosh R Ahmadi. (2010) Classical Twin Design in Modern Pharmacogenomics Studies. Pharmacogenomics 11:2, pages 215-226.
Read now
Read now
Rudolf A de Boer, Pim van der Harst, Dirk J van Veldhuisen & Maarten P van den Berg. (2009) Pharmacogenetics in heart failure: promises and challenges. Expert Opinion on Pharmacotherapy 10:11, pages 1713-1725.
Read now
Read now
Mark Glickman, Todd G. Nick & Shannon N. Saldaña. (2009) Here's to Your Health. CHANCE 22:1, pages 56-62.
Read now
Read now
Alison Hege Harrill & Ivan Rusyn. (2008) Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity. Expert Opinion on Drug Metabolism & Toxicology 4:11, pages 1379-1389.
Read now
Read now
Silvia Funke, Hermann Brenner & Jenny Chang-Claude. (2008) Pharmacogenetics in Colorectal Cancer: a Systematic Review. Pharmacogenomics 9:8, pages 1079-1099.
Read now
Read now
Upendra A Argikar, Otito F Iwuchukwu & Swati Nagar. (2008) Update on tools for evaluation of uridine diphosphoglucuronosyltransferase polymorphisms. Expert Opinion on Drug Metabolism & Toxicology 4:7, pages 879-894.
Read now
Read now
Jonathan A. Bernstein, Ge Zhang, Li Jin, Carol Abbott & Daniel W. Nebert. (2008) Olfactory Receptor Gene Polymorphisms and Nonallergic Vasomotor Rhinitis. Journal of Asthma 45:4, pages 287-292.
Read now
Read now
Articles from other publishers (121)
Daniel W. Nebert. (2024) Gene-Environment Interactions: My Unique Journey. Annual Review of Pharmacology and Toxicology 64:1, pages 1-26.
Crossref
Crossref
Karlijn de Joode, Niels Heersche, Edwin A. Basak, Sander Bins, Astrid A.M. van der Veldt, Ron H.N. van Schaik & Ron H.J. Mathijssen. (2024) Review – The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors. Cancer Treatment Reviews 122, pages 102662.
Crossref
Crossref
Rosalind Moxham, Andrew Tjokrowidjaja, Sophie Devery, Renee Smyth, Alison McLean, Darren M Roberts & Kathy H C Wu. (2023) Clinical utilities and end-user experience of pharmacogenomics: 39 mo of clinical implementation experience in an Australian hospital setting. World Journal of Medical Genetics 11:4, pages 39-50.
Crossref
Crossref
Qing Zhao, Yao Chen, Weihua Huang, Honghao Zhou & Wei Zhang. (2023) Drug-microbiota interactions: an emerging priority for precision medicine. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Almut Heinken, Johannes Hertel, Geeta Acharya, Dmitry A. Ravcheev, Malgorzata Nyga, Onyedika Emmanuel Okpala, Marcus Hogan, Stefanía Magnúsdóttir, Filippo Martinelli, Bram Nap, German Preciat, Janaka N. Edirisinghe, Christopher S. Henry, Ronan M. T. Fleming & Ines Thiele. (2023) Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. Nature Biotechnology 41:9, pages 1320-1331.
Crossref
Crossref
Tasaduq Manzoor, Irfan Ahad Dar, Aarif Ali, Tawseef Manzoor, Sheikh Bilal Ahmad, Sameena Ismail, John Mohd Muneeb, Syed Ovais, Azher Arafah & Syed Mudasir Ahmad. 2023. Pharmacogenomics. Pharmacogenomics
33
55
.
Adrijana Kekic. 2023. Pharmacogenomics in Clinical Practice. Pharmacogenomics in Clinical Practice
147
185
.
Rebecca J. Schmidt, Donghai Liang, Stefanie A. Busgang, Paul Curtin & Cecilia Giulivi. (2021) Maternal Plasma Metabolic Profile Demarcates a Role for Neuroinflammation in Non-Typical Development of Children. Metabolites 11:8, pages 545.
Crossref
Crossref
E.N. Ilina, E.M. Mayorova, A.I. Manolov, A.A. Korenkova, V.V. Bahmetjev & K.S. Gorbunov. (2021) Gut Microbiome and Drug Metabolism. Biomedical Chemistry: Research and Methods 4:1, pages e00146.
Crossref
Crossref
Mi-Ryung Han. 2021. Translational Research in Breast Cancer. Translational Research in Breast Cancer
435
453
.
Yvonne S. Lin, Kenneth E. Thummel, Brice D. Thompson, Rheem A. Totah & Christi W. Cho. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
481
550
.
Christopher Taylor, Ian Crosby, Vincent Yip, Peter Maguire, Munir Pirmohamed & Richard M. Turner. (2020) A Review of the Important Role of CYP2D6 in Pharmacogenomics. Genes 11:11, pages 1295.
Crossref
Crossref
Eun-Ji Song, Kyungsun Han, Tae-Joong Lim, Sanghyun Lim, Myung-Jun Chung, Myung Hee Nam, Hojun Kim & Young-Do Nam. (2020) Effect of probiotics on obesity-related markers per enterotype: a double-blind, placebo-controlled, randomized clinical trial. EPMA Journal 11:1, pages 31-51.
Crossref
Crossref
Jules J. Berman. 2020. Logic and Critical Thinking in the Biomedical Sciences. Logic and Critical Thinking in the Biomedical Sciences
239
260
.
Daniel W. Nebert & Ge Zhang. 2019. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics
445
486
.
Daniel W. Nebert. (2018) A Tribute to Elliot S. Vesell (1933–2018). Trends in Pharmacological Sciences 39:11, pages 905-907.
Crossref
Crossref
Jules J. Berman. 2018. Principles and Practice of Big Data. Principles and Practice of Big Data
363
372
.
Jules J. Berman. 2018. Precision Medicine and the Reinvention of Human Disease. Precision Medicine and the Reinvention of Human Disease
263
326
.
Jules J. Berman. 2018. Precision Medicine and the Reinvention of Human Disease. Precision Medicine and the Reinvention of Human Disease
69
116
.
Ines Thiele, Catherine M. Clancy, Almut Heinken & Ronan M.T. Fleming. (2017) Quantitative systems pharmacology and the personalized drug–microbiota–diet axis. Current Opinion in Systems Biology 4, pages 43-52.
Crossref
Crossref
Jessica M. HoffmanYang LyuScott D. PletcherDaniel E.L. Promislow. (2017) Proteomics and metabolomics in ageing research: from biomarkers to systems biology. Essays in Biochemistry 61:3, pages 379-388.
Crossref
Crossref
Ge Zhang & Daniel W. Nebert. (2017) Personalized medicine: Genetic risk prediction of drug response. Pharmacology & Therapeutics 175, pages 75-90.
Crossref
Crossref
David W. Hein & Denis M. Grant. 2017. Pharmacology and Therapeutics for Dentistry. Pharmacology and Therapeutics for Dentistry
63
69
.
Ashfaque Hossain, Godfred Menezes, Mohammad Al & Ibraheem Ashankyty. 2016. Food Toxicology. Food Toxicology
491
518
.
Lucia F. Jorge-Nebert, Ge Zhang, Keith M. Wilson, Zhengwen Jiang, Randall Butler, Jack L. Gluckman, Susan M. Pinney & Daniel W. Nebert. (2016) Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype. Human Genomics 10:1.
Crossref
Crossref
Jiri Polivka, Jiri PolivkaJr.Jr., Kristyna Krakorova, Marek Peterka & Ondrej Topolcan. (2016) Current status of biomarker research in neurology. EPMA Journal 7:1.
Crossref
Crossref
Renuka R. Nayak & Peter J. Turnbaugh. (2016) Mirror, mirror on the wall: which microbiomes will help heal them all?. BMC Medicine 14:1.
Crossref
Crossref
John L. Moran & Patricia J. Solomon. (2016) New initiatives in critical care: distinguishing hype from hope. Critical Care and Resuscitation 18:3, pages 141-147.
Crossref
Crossref
Alison H. Harrill. 2016. Drug Discovery Toxicology. Drug Discovery Toxicology
314
329
.
Shufeng Zhou. 2016. Cytochrome P450 2D6. Cytochrome P450 2D6
483
494
.
H. F. Merk. (2016) Porphyria cutanea tardaPorphyria cutanea tara. Der Hautarzt 67:3, pages 207-210.
Crossref
Crossref
Stephen W. Scherer & Peter M. VisscherKrishnarao Appasani & Raghu K. Appasani. 2015. Genome-Wide Association Studies. Genome-Wide Association Studies
3
11
.
Danilo Antonini Alves, Daisy Machado, Adriana Melo, Rafaella Fabiana Carneiro Pereira, Patrícia Severino, Luciana Maria de Hollanda, Daniele Ribeiro Araújo & Marcelo Lancellotti. (2016) Preparation of Thermosensitive Gel for Controlled Release of Levofloxacin and Their Application in the Treatment of Multidrug-Resistant Bacteria. BioMed Research International 2016, pages 1-10.
Crossref
Crossref
Wolfgang M. Schmidt & Robert M. Mader. 2016. Clinical Pharmacology: Current Topics and Case Studies. Clinical Pharmacology: Current Topics and Case Studies
161
183
.
Eugene Lin & Shih-Jen Tsai. 2016. Understanding Suicide. Understanding Suicide
85
95
.
Dennis J. Cheek, Lisa Bashore & Dan Alan Brazeau. (2015) Pharmacogenomics and Implications for Nursing Practice. Journal of Nursing Scholarship 47:6, pages 496-504.
Crossref
Crossref
Xiaoyan Lu, Bin Hu, Jie Zheng, Cai Ji, Xiaohui Fan & Yue Gao. (2015) Predose and Postdose Blood Gene Expression Profiles Identify the Individuals Susceptible to Acetaminophen-Induced Liver Injury in Rats. PLOS ONE 10:10, pages e0141750.
Crossref
Crossref
Dayue Darrel Duan, Zhong Wang, Bo-li Zhang & Yong-yan Wang. (2015) Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine. Acta Pharmacologica Sinica 36:6, pages 651-653.
Crossref
Crossref
Seyyed Mortaza Haghgoo, Abdolamir Allameh, Esmaeil Mortaz, Johan Garssen, Gert Folkerts, Peter J. Barnes & Ian M. Adcock. (2015) Pharmacogenomics and targeted therapy of cancer: Focusing on non-small cell lung cancer. European Journal of Pharmacology 754, pages 82-91.
Crossref
Crossref
Robert M. Ward, Justin Stiers & Karen Buchi. (2015) Neonatal Medications. Pediatric Clinics of North America 62:2, pages 525-544.
Crossref
Crossref
Scott S. Auerbach & B. Alex Merrick. 2015. Mammalian Toxicology. Mammalian Toxicology
49
73
.
Jules J. Berman. 2015. Repurposing Legacy Data. Repurposing Legacy Data
11
33
.
Susanne Michl. 2015. Individualized Medicine. Individualized Medicine
61
78
.
Andrew A Monte, Chad Brocker, Daniel W Nebert, Frank J Gonzalez, David C Thompson & Vasilis Vasiliou. (2014) Improved drug therapy: triangulating phenomics with genomics and metabolomics. Human Genomics 8:1.
Crossref
Crossref
Parasuram Krishnamoorthy, Deepansh Gupta, Saurav Chatterjee, Jessica Huston & John J. Ryan. (2014) A Review of the Role of Electronic Health Record in Genomic Research. Journal of Cardiovascular Translational Research 7:8, pages 692-700.
Crossref
Crossref
Daysi Natalia Salamanca Ortiz, Jorge Yamit Vergara Vergara, Franklin Escobar Córdoba, Álvaro Rodríguez Gama & Jorge Eduardo Caminos Pinzón. (2014) Avances genéticos y moleculares en el estudio de trastornos mentales. Revista de la Facultad de Medicina 62:2, pages 319-324.
Crossref
Crossref
Eugenia Yiannakopoulou. (2014) Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents - implications for cancer treatment and chemoprevention. Cellular Oncology 37:3, pages 167-178.
Crossref
Crossref
Wylie Burke. (2014) Genetic Tests: Clinical Validity and Clinical Utility. Current Protocols in Human Genetics 81:1.
Crossref
Crossref
Dawei Chen, Feng Guo, Jinxiu Shi, Chenhui Zhang, Zhaowen Wang, Junwei Fan & Zhihai Peng. (2014) Association of Hemoglobin Levels, CYP3A5, and NR1I3 Gene Polymorphisms with Tacrolimus Pharmacokinetics in Liver Transplant Patients. Drug Metabolism and Pharmacokinetics 29:3, pages 249-253.
Crossref
Crossref
D.W. Nebert & E.S. Vesell. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Jules J. Berman. 2014. Rare Diseases and Orphan Drugs. Rare Diseases and Orphan Drugs
191
215
.
Jules J. Berman. 2014. Rare Diseases and Orphan Drugs. Rare Diseases and Orphan Drugs
143
168
.
Kenneth E. Thummel & Yvonne S. Lin. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
363
415
.
Barkur S. Shastry. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
671
685
.
Greg Gibson. 2014. Systems Analysis of Human Multigene Disorders. Systems Analysis of Human Multigene Disorders
1
14
.
Antti Sajantila. 2014. Essentials of Autopsy Practice. Essentials of Autopsy Practice
89
104
.
A Jacunski & N P Tatonetti. (2013) Connecting the Dots: Applications of Network Medicine in Pharmacology and Disease. Clinical Pharmacology & Therapeutics 94:6, pages 659-669.
Crossref
Crossref
Kirk Hogan. 2011. Anesthetic Pharmacology. Anesthetic Pharmacology
132
146
.
Venil N. SumantranGirish Tillu. (2013) Insights on Personalized Medicine from Ayurveda. The Journal of Alternative and Complementary Medicine 19:4, pages 370-375.
Crossref
Crossref
Zheng-Jiang Zhu, Andrew W Schultz, Junhua Wang, Caroline H Johnson, Steven M Yannone, Gary J Patti & Gary Siuzdak. (2013) Liquid chromatography quadrupole time-of-flight mass spectrometry characterization of metabolites guided by the METLIN database. Nature Protocols 8:3, pages 451-460.
Crossref
Crossref
J C Stingl, J Brockmöller & R Viviani. (2012) Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function. Molecular Psychiatry 18:3, pages 273-287.
Crossref
Crossref
Daniel W. NebertGe Zhang & Elliot S. Vesell. (2013) Genetic Risk Prediction: Individualized Variability in Susceptibility to Toxicants. Annual Review of Pharmacology and Toxicology 53:1, pages 355-375.
Crossref
Crossref
Julia Stingl (formerly Kirchheiner)Jürgen Brockmöller. 2013. Pharmacogenomics. Pharmacogenomics
309
341
.
Daniel W. Nebert & Elliot S. Vesell. 2013. Emery and Rimoin's Principles and Practice of Medical Genetics. Emery and Rimoin's Principles and Practice of Medical Genetics
1
27
.
Sandhiya Selvarajan, Melvin George & Suresh Kumar Srinivasamurthy. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine
561
573
.
Rosane Charlab & Lei Zhang. 2013. Pharmacogenomics. Pharmacogenomics
3
22
.
Lucas D Ward & Manolis Kellis. (2012) Interpreting noncoding genetic variation in complex traits and human disease. Nature Biotechnology 30:11, pages 1095-1106.
Crossref
Crossref
Rashmi R. Shah & Devron R. Shah. (2012) Personalized medicine: is it a pharmacogenetic mirage?. British Journal of Clinical Pharmacology 74:4, pages 698-721.
Crossref
Crossref
D. W. NebertG. Zhang. (2012) Personalized Medicine: Temper Expectations. Science 337:6097, pages 910-910.
Crossref
Crossref
T. Yamamura, J. Hikita, M. Bleakley, T. Hirosawa, A. Sato‐Otsubo, H. Torikai, T. Hamajima, Y. Nannya, A. Demachi‐Okamura, E. Maruya, H. Saji, Y. Yamamoto, T. Takahashi, N. Emi, Y. Morishima, Y. Kodera, K. Kuzushima, S. R. Riddell, S. Ogawa & Y. Akatsuka. (2012) HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype. Tissue Antigens 80:2, pages 119-125.
Crossref
Crossref
Simon M. McHugh, Shilina Roman, Bill Davis, Annelize Koch, Alison M. Pickett, Jill C. Richardson, Sam R. Miller, Sally Wetten, Charles J. Cox, Fredrik Karpe, John A. Todd & Edward T. Bullmore. (2012)
Effects of genetic variation in the
P2RX7
gene on pharmacodynamics of a P2X
7
receptor antagonist: a prospective genotyping approach
. British Journal of Clinical Pharmacology 74:2, pages 376-380.
Crossref
Crossref
S L Chan, C Suo, S C Lee, B C Goh, K S Chia & Y Y Teo. (2011) Translational aspects of genetic factors in the prediction of drug response variability: a case study of warfarin pharmacogenomics in a multi-ethnic cohort from Asia. The Pharmacogenomics Journal 12:4, pages 312-318.
Crossref
Crossref
Anthony Y. H. Lu & Qiang Ma. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
95
107
.
Jose de Leon. (2012) Evidence-Based Medicine Versus Personalized Medicine. Journal of Clinical Psychopharmacology 32:2, pages 153-164.
Crossref
Crossref
Ai-Ming Yu & Yu-Zhuo Pan. (2012) Noncoding microRNAs: small RNAs play a big role in regulation of ADME?. Acta Pharmaceutica Sinica B 2:2, pages 93-101.
Crossref
Crossref
T A P Lett, T J M Wallace, N I Chowdhury, A K Tiwari, J L Kennedy & D J Müller. (2011) Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Molecular Psychiatry 17:3, pages 242-266.
Crossref
Crossref
Andrew A. Monte, Kennon J. Heard & Vasilis Vasiliou. (2011) Prediction of Drug Response and Safety in Clinical Practice. Journal of Medical Toxicology 8:1, pages 43-51.
Crossref
Crossref
Caroline H. JohnsonAndrew D. PattersonJeffrey R. IdleFrank J. Gonzalez. (2012) Xenobiotic Metabolomics: Major Impact on the Metabolome. Annual Review of Pharmacology and Toxicology 52:1, pages 37-56.
Crossref
Crossref
Mladen Tzvetkov & Nicolas von Ahsen. (2012) Pharmacogenetic screening for drug therapy: From single gene markers to decision making in the next generation sequencing era. Pathology 44:2, pages 166-180.
Crossref
Crossref
Atsushi Watanabe. (2012) Pharmacogenomics and Personalized Medicine. Nihon Ika Daigaku Igakkai Zasshi 8:1, pages 9-17.
Crossref
Crossref
Scott R. Diehl, Chih-Hung Chou, Fengshen Kuo & Ching-Yu Huang. 2012. Carranza's Clinical Periodontology. Carranza's Clinical Periodontology
271
284
.
Antoine Ho, Maurice Murphy, Susan Wilson, Susan R Atlas & Jeremy S Edwards. (2011) Sequencing by ligation variation with endonuclease V digestion and deoxyinosine-containing query oligonucleotides. BMC Genomics 12:1.
Crossref
Crossref
Ramy K Aziz, Rama Saad & Mariam R Rizkallah. (2011) PharmacoMicrobiomics or how bugs modulate drugs: an educational initiative to explore the effects of human microbiome on drugs. BMC Bioinformatics 12:S7.
Crossref
Crossref
Richard J. Hift, Stig Thunell & Atle Brun. (2011) Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity. Pharmacology & Therapeutics 132:2, pages 158-169.
Crossref
Crossref
Munir Pirmohamed. (2011) Pharmacogenetics: past, present and future. Drug Discovery Today 16:19-20, pages 852-861.
Crossref
Crossref
Qiang Ma & Anthony Y. H. Lu. (2011) Pharmacogenetics, Pharmacogenomics, and Individualized Medicine. Pharmacological Reviews 63:2, pages 437-459.
Crossref
Crossref
Carmen Ayuso, Juan José Tellería, Juan Carlos Tejedor & Diego Gracia. (2011) Ética en investigación genética (2). Estudios de susceptibilidad. Medicina Clínica 137:1, pages 22-26.
Crossref
Crossref
Carmen Ayuso, Francisco Abad-Santos, Rafael Dal-R?Diego Gracia. (2011) ?tica en investigaci?n gen?tica (1). Estudios farmacogen?ticos. Medicina Cl?nica 136:15, pages 678-682.
Crossref
Crossref
Cinnamon S. Bloss, Dilip V. Jeste & Nicholas J. Schork. (2011) Genomics for Disease Treatment and Prevention. Psychiatric Clinics of North America 34:1, pages 147-166.
Crossref
Crossref
Hidetaka Torigoe, Akira Ono & Tetsuo Kozasa. (2010) Detection of single nucleotide polymorphisms by the specific interaction between transition metal ions and mismatched base pairs in duplex DNA. Transition Metal Chemistry 36:2, pages 131-144.
Crossref
Crossref
Terri S. Armstrong & Mark R. Gilbert. (2010) Patient Profiling for Treatment Toxicity: Potential Use of Clinical and Genomic Factors. Current Oncology Reports 13:1, pages 37-41.
Crossref
Crossref
Daniel A. Brazeau & Gayle A. Brazeau. 2011. Principles of the Human Genome and Pharmacogenomics. Principles of the Human Genome and Pharmacogenomics.
Heon-Jeong Lee & Seung-Gul Kang. 2011. Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia. Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia
231
264
.
Giancarlo Liumbruno, Angelo D’Alessandro, Giuliano Grazzini & Lello Zolla. (2010) How has proteomics informed transfusion biology so far?. Critical Reviews in Oncology/Hematology 76:3, pages 153-172.
Crossref
Crossref
Michael Rutter. (2010) Child and adolescent psychiatry: past scientific achievements and challenges for the future. European Child & Adolescent Psychiatry 19:9, pages 689-703.
Crossref
Crossref
K. G. Claw, R. Y. Tito, A. C. Stone & B. C. Verrelli. (2010) Haplotype Structure and Divergence at Human and Chimpanzee Serotonin Transporter and Receptor Genes: Implications for Behavioral Disorder Association Analyses. Molecular Biology and Evolution 27:7, pages 1518-1529.
Crossref
Crossref
Andrew G. SmithGeorge H. Elder. (2010) Complex Gene−Chemical Interactions: Hepatic Uroporphyria As a Paradigm. Chemical Research in Toxicology 23:4, pages 712-723.
Crossref
Crossref
Olivier Blanc, Georges Brousse, Alexandre Meary, Marion Leboyer & Pierre‐Michel Llorca. (2010) Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research. Fundamental & Clinical Pharmacology 24:2, pages 139-160.
Crossref
Crossref
John S. Witte. (2010) Genome-Wide Association Studies and Beyond. Annual Review of Public Health 31:1, pages 9-20.
Crossref
Crossref
Alessio Squassina, Mirko Manchia & Maria Del Zompo. (2010) Pharmacogenomics of Mood Stabilizers in the Treatment of Bipolar
Disorder. Human Genomics and Proteomics 2:1.
Crossref
Crossref
Giancarlo Liumbruno, Angelo D'Alessandro, Giuliano Grazzini & Lello Zolla. (2010) Blood-related proteomics. Journal of Proteomics 73:3, pages 483-507.
Crossref
Crossref
Andrea Farkas Patenaude. 2010. Molecular Diagnostics. Molecular Diagnostics
549
562
.
E.A. Lock. 2010. Comprehensive Toxicology. Comprehensive Toxicology
55
79
.
Wolfgang M. Schmidt. 2010. Clinical Pharmacology: Current Topics and Case Studies. Clinical Pharmacology: Current Topics and Case Studies
205
223
.
Justine A. Ellis. 2010. Aging Hair. Aging Hair
221
232
.
Dalia Kasperavičiūtė & Sanjay M. Sisodiya. 2010. Atlas of Epilepsies. Atlas of Epilepsies
1593
1598
.
J. S. Forbey & W. J. Foley. (2009) PharmEcology: A pharmacological approach to understanding plant-herbivore interactions: an introduction to the symposium. Integrative and Comparative Biology 49:3, pages 267-273.
Crossref
Crossref
Christine P. Curran, Robert M. Park, Shuk-mei Ho & Erin N. Haynes. (2009) Incorporating genetics and genomics in risk assessment for inhaled manganese: From data to policy. NeuroToxicology 30:5, pages 754-760.
Crossref
Crossref
T. Andrew ClaytonDavid Baker, John C. LindonJeremy R. Everett & Jeremy K. Nicholson. (2009) Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proceedings of the National Academy of Sciences 106:34, pages 14728-14733.
Crossref
Crossref
Daniel A. Brazeau & Gayle A. Brazeau. (2009) Role of the Genomics Revolution in Pharmaceutics. Laboratory Medicine 40:5, pages 261-266.
Crossref
Crossref
Sylvie Giroux & Fran?ois Rousseau. (2009) Genes and osteoporosis: time for a change in strategy. International Journal of Clinical Rheumatology 4:2, pages 221-233.
Crossref
Crossref
Hongbin Dong, Timothy P. Dalton, Marian L. Miller, Ying Chen, Shigeyuki Uno, Zhanquan Shi, Howard G. Shertzer, Seema Bansal, Narayan G. Avadhani & Daniel W. Nebert. (2009)
Knock-In Mouse Lines Expressing either Mitochondrial or Microsomal CYP1A1: Differing Responses to Dietary Benzo[
a
]pyrene as Proof of Principle
. Molecular Pharmacology 75:3, pages 555-567.
Crossref
Crossref
Mark Glickman, Todd G. Nick & Shannon N. Saldaña. (2009) Pharmacogenetics and pharmacogenomics: Statistical challenges in design and analysis. CHANCE 22:1, pages 56-62.
Crossref
Crossref
Vural OzdemirArno G. MotulskyEugene KolkerBéatrice Godard. (2009) Genome–Environment Interactions and Prospective Technology Assessment: Evolution from Pharmacogenomics to Nutrigenomics and Ecogenomics. OMICS: A Journal of Integrative Biology 13:1, pages 1-6.
Crossref
Crossref
Vural OzdemirGuilherme Suarez-KurtzRaphaëlle StenneAndrew A. SomogyiToshiyuki SomeyaS. Oğuz KayaalpEugene Kolker. (2009) Risk Assessment and Communication Tools for Genotype Associations with Multifactorial Phenotypes: The Concept of “Edge Effect” and Cultivating an Ethical Bridge between Omics Innovations and Society. OMICS: A Journal of Integrative Biology 13:1, pages 43-61.
Crossref
Crossref
James J Kohler, Seyed H Hosseini, Ioan Cucoranu, Amy Hoying-Brandt, Elgin Green, David Johnson, Bree Wittich, Jaya Srivastava, Kristopher Ivey, Earl Fields, Rodney Russ, C Michael Raper, Robert Santoianni & William Lewis. (2008) Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylation. Laboratory Investigation 89:2, pages 122-130.
Crossref
Crossref
Jose de Leon. (2009) The future (or lack of future) of personalized prescription in psychiatry. Pharmacological Research 59:2, pages 81-89.
Crossref
Crossref
Jose de Leon. (2008) Pharmacogenomics: The Promise of Personalized Medicine for CNS Disorders. Neuropsychopharmacology 34:1, pages 159-172.
Crossref
Crossref
Wylie Burke. (2009) Clinical Validity and Clinical Utility of Genetic Tests. Current Protocols in Human Genetics 60:1.
Crossref
Crossref
Olavi Pelkonen, Miia Turpeinen, Jukka Hakkola, Paavo Honkakoski, Janne Hukkanen & Hannu Raunio. (2008) Inhibition and induction of human cytochrome P450 enzymes: current status. Archives of Toxicology 82:10, pages 667-715.
Crossref
Crossref
Antonio Drago, Diana De Ronchi & Alessandro Serretti. (2008) Pharmacogenetics of antidepressant response: An update. Human Genomics 3:3, pages 257.
Crossref
Crossref